Question: Minimal residual disease (MRD) detection thresholds in hematologic cancers
Solution_eval: applicability of next-generation flow cytometry for AML MRD in routine labs
Collecting findings
0/4 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected